Company Filing History:
Years Active: 2020-2021
Title: **David Schriebman: Innovator in Biomedical Imaging Technology**
Introduction
David Schriebman, residing in Berkeley, CA, is a distinguished inventor known for his contributions to biomedical imaging technology. With a total of two patents to his name, he has developed groundbreaking methods that significantly advance the field of non-invasive real-time imaging of neural and vascular activity.
Latest Patents
Schriebman's latest patents focus on a novel method and apparatus for non-invasive real-time biomedical imaging. His innovative approach allows for the creation of biomedical images that reveal both anatomical structures and real-time changes in neuronal, metabolic, positional, and vascular function in both humans and animals. Utilizing ultra-wideband (UWB) pulse or square wave generators and electrical samplers, these inventions employ integrated circuits to assemble arrays of miniaturized microwave modules. These modules are strategically placed around the area of interest in the body or head, providing the capability to capture images via time-domain transmission of pulsed waves or time-domain reflectivity from internal structures. Furthermore, advanced signal processing techniques are employed to separate and extract time-varying functional information from static structural image data, thereby enabling interpretations that can control prosthetics and Brain-Machine Interfaces.
Career Highlights
David Schriebman has made notable advancements in his field through his innovative work at Furaxa, Inc. His dedication to developing sophisticated biomedical imaging techniques has positioned him at the forefront of research and application in this critical area of healthcare technology.
Collaborations
Throughout his career, Schriebman has collaborated with notable coworkers, including Joel M. Libove and Mike Ingle. These partnerships have fostered a collaborative environment that promotes innovation and the sharing of ideas, facilitating the advancement of cutting-edge biomedical imaging technologies.
Conclusion
David Schriebman's innovative work in the field of biomedical imaging underscores the significance of non-invasive techniques in understanding complex biological functions. His contributions, especially through his patents, will likely pave the way for new capabilities in brain-machine interfaces and other biomedical applications, further enhancing the potential for technological integration in healthcare.